Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings
New York, Jan 9, 2026, 15:46 EST — Regular session Arcutis Biotherapeutics shares slid 5.3% to $28.29 in afternoon trading on Friday, after climbing as high as $30.70 earlier. The stock was last at the session low. The move followed a cooler U.S. payrolls report, which reinforced expectations the Federal Reserve will keep rates steady in coming weeks. High-growth biotech…